BIOMAT Database Logo BIOMAT Database Logo

COVID-19 Case Fatality and Alzheimer's Disease. 2021

Qiang Zhang, and Jordan L Schultz, and Georgina M Aldridge, and Jacob E Simmering, and Youngcho Kim, and Amy C Ogilvie, and Nandakumar S Narayanan
Department of Neurology, University of Iowa, Iowa City, IA, USA.

Previous studies have identified dementia as a risk factor for death from coronavirus disease 2019 (COVID-19). However, it is unclear whether Alzheimer's disease (AD) is an independent risk factor for COVID-19 case fatality rate. In a retrospective cohort study, we identified 387,841 COVID-19 patients through TriNetX. After adjusting for demographics and comorbidities, we found that AD patients had higher odds of dying from COVID-19 compared to patients without AD (Odds Ratio: 1.20, 95%confidence interval: 1.09-1.32, p < 0.001). Interestingly, we did not observe increased mortality from COVID-19 among patients with vascular dementia. These data are relevant to the evolving COVID-19 pandemic.

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015140 Dementia, Vascular An imprecise term referring to dementia associated with CEREBROVASCULAR DISORDERS, including CEREBRAL INFARCTION (single or multiple), and conditions associated with chronic BRAIN ISCHEMIA. Diffuse, cortical, and subcortical subtypes have been described. (From Gerontol Geriatr 1998 Feb;31(1):36-44) Arteriosclerotic Dementia,Binswanger Disease,Encephalopathy, Binswanger,Leukoencephalopathy, Subcortical,Subcortical Arteriosclerotic Encephalopathy,Vascular Dementia,Acute Onset Vascular Dementia,Arteriosclerotic Encephalopathy, Subcortical,Binswanger Encephalopathy,Binswanger's Disease,Chronic Progressive Subcortical Encephalopathy,Encephalopathy, Binswanger's,Encephalopathy, Chronic Progressive Subcortical,Encephalopathy, Subcortical Arteriosclerotic,Encephalopathy, Subcortical, Chronic Progressive,Subcortical Encephalopathy, Chronic Progressive,Subcortical Leukoencephalopathy,Subcortical Vascular Dementia,Vascular Dementia, Acute Onset,Arteriosclerotic Dementias,Arteriosclerotic Encephalopathies, Subcortical,Binswanger's Encephalopathy,Binswangers Disease,Dementia, Arteriosclerotic,Dementia, Subcortical Vascular,Dementias, Arteriosclerotic,Dementias, Subcortical Vascular,Dementias, Vascular,Disease, Binswanger,Disease, Binswanger's,Encephalopathies, Subcortical Arteriosclerotic,Encephalopathy, Binswangers,Leukoencephalopathies, Subcortical,Subcortical Arteriosclerotic Encephalopathies,Subcortical Leukoencephalopathies,Subcortical Vascular Dementias,Vascular Dementia, Subcortical,Vascular Dementias,Vascular Dementias, Subcortical

Related Publications

Qiang Zhang, and Jordan L Schultz, and Georgina M Aldridge, and Jacob E Simmering, and Youngcho Kim, and Amy C Ogilvie, and Nandakumar S Narayanan
Infection fatality ratio and case fatality ratio of COVID-19.
December 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Qiang Zhang, and Jordan L Schultz, and Georgina M Aldridge, and Jacob E Simmering, and Youngcho Kim, and Amy C Ogilvie, and Nandakumar S Narayanan
Estimating case fatality rates of COVID-19.
July 2020, The Lancet. Infectious diseases,
Qiang Zhang, and Jordan L Schultz, and Georgina M Aldridge, and Jacob E Simmering, and Youngcho Kim, and Amy C Ogilvie, and Nandakumar S Narayanan
Estimating case fatality rates of COVID-19.
July 2020, The Lancet. Infectious diseases,
Qiang Zhang, and Jordan L Schultz, and Georgina M Aldridge, and Jacob E Simmering, and Youngcho Kim, and Amy C Ogilvie, and Nandakumar S Narayanan
Estimating case fatality rates of COVID-19.
July 2020, The Lancet. Infectious diseases,
Qiang Zhang, and Jordan L Schultz, and Georgina M Aldridge, and Jacob E Simmering, and Youngcho Kim, and Amy C Ogilvie, and Nandakumar S Narayanan
COVID-19 and Alzheimer's Disease.
February 2021, Brain sciences,
Qiang Zhang, and Jordan L Schultz, and Georgina M Aldridge, and Jacob E Simmering, and Youngcho Kim, and Amy C Ogilvie, and Nandakumar S Narayanan
Treatment and case fatality rate of COVID-19 in Africa.
September 2022, Journal of public health in Africa,
Qiang Zhang, and Jordan L Schultz, and Georgina M Aldridge, and Jacob E Simmering, and Youngcho Kim, and Amy C Ogilvie, and Nandakumar S Narayanan
Case fatality rate analysis of Italian COVID-19 outbreak.
July 2020, Journal of medical virology,
Qiang Zhang, and Jordan L Schultz, and Georgina M Aldridge, and Jacob E Simmering, and Youngcho Kim, and Amy C Ogilvie, and Nandakumar S Narayanan
National case fatality rates of the COVID-19 pandemic.
January 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Qiang Zhang, and Jordan L Schultz, and Georgina M Aldridge, and Jacob E Simmering, and Youngcho Kim, and Amy C Ogilvie, and Nandakumar S Narayanan
Case Fatality Rate of COVID-19: Meta-Analysis Approach.
September 2020, Archives of Iranian medicine,
Qiang Zhang, and Jordan L Schultz, and Georgina M Aldridge, and Jacob E Simmering, and Youngcho Kim, and Amy C Ogilvie, and Nandakumar S Narayanan
COVID-19 Infection Fatality Rates.
August 2020, Health affairs (Project Hope),
Copied contents to your clipboard!